Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2005
10/12/2005CN1680350A Crystalline base of citalopram
10/12/2005CN1680343A New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
10/12/2005CN1680332A Method for producing amine derivative
10/12/2005CN1680326A Pharmaceutical compositions and methods for use
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1680284A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/12/2005CN1680280A Method for producing amine derivative
10/12/2005CN1680279A Phenoxyhydrindone derivatives containing nitrogen and preparation and use thereof
10/12/2005CN1679963A Coupling agent of CB and specific immune globulin IgG and use thereof
10/12/2005CN1679955A Compositions for improving drug safety
10/12/2005CN1679941A Compound preparation consisting of taurine and medicines for hepatopathy and production thereof
10/12/2005CN1679937A Compositions and methods for treating or preventing inflammatory diseases
10/12/2005CN1679935A Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist
10/12/2005CN1679909A Chinese medicine composition for treating hyposomnia and preparation thereof
10/12/2005CN1679890A Sobering up infusion granule and preparation thereof
10/12/2005CN1679867A Compound tall gastrodia tuber preparation and production thereof
10/12/2005CN1679750A Anxiolytic matter extracted from preparata
10/12/2005CN1679743A Chinese medicine herb prescription for treating neuralgia and capital necrosis
10/12/2005CN1679739A Oral medicinal preparation against drug addiction and its preparing method
10/12/2005CN1679738A Medicinal cigarettes against drug addiction
10/12/2005CN1679717A External-applied medicine for treating terminal neuritis and preparation thereof
10/12/2005CN1679713A Sobering up use of camphor tree fruit
10/12/2005CN1679709A External-applied resuscitation-reducing washing liquid for treating cephalagia and preparation thereof
10/12/2005CN1679691A Medicine for treating encephalatrophy and preparation thereof
10/12/2005CN1679681A Chinese medicine preparation for treating senile dementia and preparation thereof
10/12/2005CN1679677A Danqi drops for activating blood and eliminating blood stasis and preparation thereof
10/12/2005CN1679665A Preparation of sobering up tea
10/12/2005CN1679657A Extract of perilla and its use in preparation of medicine
10/12/2005CN1679652A Medicine for detoxification
10/12/2005CN1679637A Biological medicine for treating diseases from infection viral and bacterial
10/12/2005CN1679632A Aqueous extracts of analgesic from woodfrog and its preparation
10/12/2005CN1679624A 磁药 Magnetic drug
10/12/2005CN1679623A Injection for treating facial tic
10/12/2005CN1679611A Compound preparation of piracetam and its use
10/12/2005CN1679603A Use of kaempferol-3-O-glubulariacitrin in preparing medicine for senile dementia
10/12/2005CN1679602A Use of kaempferol and its derivative in preparing medicines for depression or dementia
10/12/2005CN1679599A Double-layer delayed-releasing tablet of seudo-ginseng general saponin and production thereof
10/12/2005CN1679591A Steroidal sapogenins and their derivatives for treating alzheimer's disease
10/12/2005CN1679588A Medicinal composition for treating mimic tic
10/12/2005CN1679586A Novel synthesis and crystallization of piperazine ring-containing compounds
10/12/2005CN1679583A Pharmaceutical composition comprising condensed indole compound
10/12/2005CN1679577A Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
10/12/2005CN1679572A Medicinal injection for treating primary mimic tic
10/12/2005CN1679565A Injection of pyritinol hydrochloride and its preparation
10/12/2005CN1679564A Method of treating of demyelinating diseases or conditions
10/12/2005CN1679562A Antiviral compounds
10/12/2005CN1679561A Nimodipine gel for nasal cavity
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679552A Preferential inhibition of release of pro-inflammatory cytokines
10/12/2005CN1679532A Therapeutic and dietary compositions
10/12/2005CN1679528A Danshensu and its sodium salt for preventing from and treating various regressive nervous diseases
10/12/2005CN1679523A Analgesic injecting powder preparation and preparation thereof
10/12/2005CN1679521A Use of substituting nitrobenzene derivative in products preparation
10/12/2005CN1679520A Compound analgesic agent
10/12/2005CN1679515A Slow-releasing polymer microglobe of analgesic and preparation thereof
10/12/2005CN1222529C Water soluble rapamycin esters
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/12/2005CN1222525C Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222517C Method for preparing xitaipulan
10/12/2005CN1222511C I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands
10/12/2005CN1222509C Prostaglandin derives.
10/12/2005CN1222374C Extrusion die
10/12/2005CN1222307C Nutrient extract for dispelling effects of alcohol
10/12/2005CN1222291C Novel uses of combined 5-HT 1A agonists and serotonin reuptake inhibitor
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/12/2005CN1222287C Pharmaceutical formulations contg. zolmitriptan
10/12/2005CN1222286C Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
10/11/2005US6953854 Process for preparing crystalline Form I of cabergoline
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953838 Urocortin-III and uses thereof
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953805 Ethyl 6-(((2S)-2-(Ethoxycarbonyl)-4,4-difluoropyrrolidinyl)methyl)-1,2,3,4,4a, 5,6,7,8,8a-decahydroisoquinoline-3-carboxylate, treating migraine pain without attending side effects
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953794 Monitoring treatment for nervous system didorders; obtain cell sample containing tau protein, incubate with modulator, monitor tau binding, adjustment in tau binding indicates modulators
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953790 CGRP receptor antagonists
10/11/2005US6953787 5HT2C receptor modulators
10/11/2005US6953681 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/11/2005US6953667 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
10/11/2005US6953661 Method of preventing transport of a neurotropic virus and identifying agents for achieving same
10/11/2005US6953595 Inhibitors of apoptosis of nerve cells
10/11/2005US6953591 Administering to a mammal non-toxic effective T-cell function-mediated disorder-treating amount of phosphatidyl serine (PS) carrying bodies wherein progression of T-cell function-mediated disorder is inhibited
10/11/2005US6953575 Methods of treating central nervous system disorders using viral vectors
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/11/2005CA2282277C Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
10/06/2005WO2005093082A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor
10/06/2005WO2005093067A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005092875A1 Crystalline citalopram diol intermediate alkali
10/06/2005WO2005092873A2 Thiadiazoles for treatment of cancer or neurological disease
10/06/2005WO2005092392A2 Conjugated psychotropic drugs and uses thereof
10/06/2005WO2005092366A1 TREATMENT OF NEUROLOGICAL CONDITIONS USING COMPLEMENT C5a RECEPTOR MODULATORS
1 ... 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 ... 1833